GE HealthCare Technologies (GEHC) Cash & Equivalents (2022 - 2026)

GE HealthCare Technologies (GEHC) has 5 years of Cash & Equivalents data on file, last reported at $2.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 7.71% year-over-year to $2.3 billion; the trailing twelve-month figure through Mar 2026 stood at $2.3 billion (down 7.71% YoY), and the FY2025 full-year result was $4.5 billion, up 56.07% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $2.3 billion, down from $4.5 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $4.5 billion in Q4 2025 and bottomed at $504.0 million in Q3 2022.
• The 5-year median for Cash & Equivalents is $2.4 billion (2023), against an average of $2.4 billion.
• The widest annual swing landed in 2023, when Cash & Equivalents jumped 380.16%; it then decreased 7.71% in 2026.
• A 5-year view of Cash & Equivalents shows it stood at $1.5 billion in 2022, then soared by 72.71% to $2.5 billion in 2023, then increased by 15.44% to $2.9 billion in 2024, then soared by 56.07% to $4.5 billion in 2025, then plunged by 49.39% to $2.3 billion in 2026.
• The last three Cash & Equivalents figures came in at $2.3 billion (Q1 2026), $4.5 billion (Q4 2025), and $4.0 billion (Q3 2025), per Business Quant data.

Peer Comparison